Should you buy Oscar Health stock? 3-minute stock analysis - July 2025

Published first at https://www.3minutebreakdowns.com Oscar Health stock analysis. Ticker: $OSCR Oscar Health has caught the attention of investors due to its rapid growth and some investors think the stock could 5 or even 10x in value. So let's take a closer look. At the latest share price of $19, Oscar Health has a current market cap around 5.8 billion.. The company has over 3 billion of cash and investments but most of it is needed for insurance operations so I put the true enterprise value at 5.6 billion. Meanwhile, the company has reported 10 billion of revenue over the last 12 months, 123 million of net income and 508 million of adjusted ebitda. So the stock is trading at 47 times earnings and 11 times ebitda. Oscar Health is attempting to disrupt health insurance in the US with a technology-driven approach that focuses on individuals and small businesses. The rise of freelancing and the gig economy has created a large pool of individuals that would like insurance and Oscar has been riding this trend successfully. Since December 2020, members have grown from 400,000 to over 2 million and annual revenues have increased over 2000 percent. Last year, the company posted its first ever GAAP profit. ABOUT ME Joe is the original founder of 3-minute Breakdowns and editor for Overlooked Alpha, the number one newsletter for overlooked investing ideas and stock market analysis. Joe evaluates companies from a business-first perspective, searching for things that the market has got wrong and waiting for the 'fat pitch'. LINKS My website: https://www.3minutebreakdowns.com/ Koyfin charts: https://www.koyfin.com/affiliate/overlooked-alpha/?via=3mb TikTok: https://www.tiktok.com/@overlookedalpha X: https://x.com/OverlookedAlpha DISCLAIMER & DISCLOSURE This content is for educational and entertainment purposes only. 3-Minute Breakdowns is not a registered investment advisor and does not provide financial recommendations (only opinions). The information is being presented without consideration of the investment objectives, risk tolerance, or financial circumstances of any specific investor and might not be suitable for all investors. Past performance is not indicative of future results. All investing involves risk, including the possible loss of principal. The author reserves the right to buy and sell or change his position in a particular stock at any time. This description contains affiliate links that allow you to find the items that I personally use and recommend. Thank you for your support.